Abstract
Catabolic pathways change in anabolic diseases such as cancer to maintain metabolic homeostasis. The liver urea cycle (UC) is the main catabolic pathway for disposing excess nitrogen. Outside the liver, the UC enzymes are differentially expressed based on each tissue's needs for UC intermediates. In tumors, there are changes in the expression of UC enzymes selected for promoting tumorigenesis by increasing the availability of essential UC substrates and products. Consequently, there are compensatory changes in the expression of UC enzymes in the cells that compose the tumor microenvironment. Moreover, extrahepatic tumors induce changes in the expression of the liver UC, which contribute to the systemic manifestations of cancer, such as weight loss. Here, we review the multilayer changes in the expression of UC enzymes throughout carcinogenesis. Understanding the changes in UC expression in the tumor and its micro and macro environment can help identify biomarkers for early cancer diagnosis and vulnerabilities that can be targeted for therapy.
Original language | English |
---|---|
Article number | a041538 |
Journal | Cold Spring Harbor perspectives in medicine |
Volume | 14 |
Issue number | 4 |
Early online date | 11 Sept 2023 |
DOIs | |
Publication status | Published - 1 Apr 2024 |
Bibliographical note
A.E. is supported by research grants from the European research program (ERC 818943), the Israel Science Foundation (860/18), and The Israel Cancer Research Fund (837124). A.E. received additional support from The Moross Integrated Cancer Center, Blumberg Family Research Fellow Chair in Honor of Talia LynnSteckman, from Manya and Adolph Zarovinsky, and the Koret Foundation. S.P. is funded by the Sergio Lombroso Postdoctoral Fellowship. We have a paid license to use BioRender through the Weizmann Institute.
All Science Journal Classification (ASJC) codes
- General Biochemistry,Genetics and Molecular Biology